Skip to main content
. 2020 May 27;176(2):396–409. doi: 10.1093/toxsci/kfaa069

Figure 6.

Figure 6.

Human neural progenitor cells treated with control (red), 3 µM (green), or 30 µM (blue) lead acetate (GSE84712). Daily RNA-sequencing analysis was performed until 26 days. Estimation of cell proportions (dataset used as reference panel: GSE95315) of oligodendrocyte precursors (A), neuronal intermediate progenitors (B), and neuroblasts (C). Expression levels in transcripts per million (TPM) of key oligodendrocyte genes OLIG1 (D), OLIG2 (E), OLIG3 (F), and MBP (G) are shown.